TAILIEUCHUNG - VIRGINIA - The SBA: Streamlining and Simplifying

The wording was changed on eight prob- lems for greater clarity. Still, the list of potential business problems assessed in 2012 closely resembles the list produced in prior years. The publication format is also similar in all editions. The publications begin with an overview of results from the total population of small-busi- ness owner respondents. They then examine the most important problems, the least impor- tant problems, problems on which there is most and least consensus, the relative importance of various problems clustered by topic, changes in ranking from prior surveys, etc. The bulk of the publications review owner assessments of the problem. | VIRGINIA BUSINESS RESOURCE The SBA Streamlining and Simplifying page 33 Counseling PAGE 8 Capital PAGE 18 Contracting PAGE 34 connect with us @ Ý SBAgov Ồ sbagov sba SMALL BUSINESS content 2012-2013 VIRGINIA FEATURES 4 Introduction 4 Administrator s Message 5 Regional Administrators Message 6 District Director s Letter 8 18 Counseling Getting Help to Start Up Market and Manage Your Business 8 SBA Resource Partners 12 SBA s Online Tools and Training 13 Reaching Underserved Communities 15 Are You Right for Small Business Ownership 16 Writing a Business Plan Capital Financing Options to Start or Grow Your Business 18 SBA Business Loans 19 What to Take to the Lender 27 Small Business Investment Company Program 27 Small Business Innovation Research Program 28 Small Business Technology Transfer Program 28 Surety Bond Guarantee Program 30 SBA Loan Program Chart 32 SBA Lenders Program Chart 33 Feature Article The SBA Streamlining and Simplifying 34 Contracting Applying for Government Contracts 34 How Government Contracting Works 35 SBA Contracting Programs 38 Getting Started in Contracting 39 Disaster Assistance Getting Back on Your Feet After a Disaster 40 Advocacy and Ombudsman Watching Out for Small Business Interests 41 Additional Resources Taking Care of Start Up Logistics 45 Business Organization Choosing your Structure 47 Other Assistance 58 Lender Listing On the Cover Welder Scott Belden at work at the manufacturing facility of his employer Tulsa Economasters LLC. Reni Publishing Publishers of Small Business Resource Advertising Phone 863-294-2812 800-274-2812 Fax 863-299-3909 Staff President CEO Joe Jensen jjensen@ English Spanish Small Business Resource Advertising Nicky Roberts Martha Theriault Kenna Rogers Production Diane Traylor nroberts@ mtheriault@ krogers@ dtraylor@ SBA s Marketing Office The Small Business Resource Guide is published .

• Tài chính doanh nghiệp
• Pancreatic Cancer
• Network Centric Understanding
• Systems
• Pancreatic Ductal
• Adenocarcinoma Signalling
• Novel Biomarkers
• BMC Cancer
• Pancreatic carcinoma
• Pancreatic exocrine insufficiency
• Unresectable pancreatic cancer
• Pancreatic enzyme replacement therapy
• Recurrent pancreatic ductal adenocarcinoma
• Recurrent pancreatic cancer
• Metastatic pancreatic cancer
• Gemcitabine nab paclitaxel
• Combination chemotherapy
• Pancreatic ductal adenocarcinoma
• Neoadjuvant chemotherapy
• Perioperative chemotherapy
• Randomized trial
• Pancreatic stellate cells
• Extracellular matrix
• PSC CM induced chemoresistance
• Overall survival
• Pancreatic intraepithelial neoplasia
• Cancer stem cells
• Tumor stroma
• Tumor microenvironment
• Recurrence pattern
• Pancreatic neoplasm
• Pancreatic juice
• Mutation analysis
• Liquid biopsy
• Elderly patient
• Non surgical treatment
• Charlson comorbidity index
• Physical activity
• Life course
• Pancreatic cancer risk
• Life course physical activity
• Differential diagnosis
• Pancreatic head cancer
• Distal cholangiocarcinoma
• Histopathological similarity
• Liver metastases
• Unexpected liver metastasis
• Peritoneal carcinomatosis
• Advanced disease
• Lethal cancers
• Cancer incidence
• Locally advanced pancreatic cancer
• Induction chemotherapy
• Salvage therapy
• Prognostic factor
• Borderline resectable pancreatic cancer
• Neoadjuvant chemoradiotherapy
• Progression of vascular invasion
• Confidence interval
• Cancer stem cell
• Protein kinase C
• Nab paclitaxel
• Lymphoid cell types
• Tumor growth
• Human clinical treatment
• Neoadjuvant therapy
• Anatomically widely spread
• Intensity modulated radiation therapy
• Advanced cancer
• Biliary tract cancer
• Lung cancer
• Multimodal intervention
• Enzyme gamma glutamyltransferase
• Serum gamma glutamyltransferase
• Tumor cell proliferation
• Tumor progression
• Human pancreatic cancer
• Severity assessment
• Animal models
• Murine model of pancreatic cancer
• Non invasive methods compared
• European surgeons
• Hormone sensitive lipase
• Adipose tissue inflammation
• Pancreatic inflammation
• Animal model
• H 1 parvovirus
• Oncolytic virotherapy
• Clinical protocol